Analysis of Biological Progression and Regression of HELLP Syndrome in Time

CHU Mohammed VI Marrakech70 enrolled

Overview

Prospective observational study about progression and regression of biological parameters of HELLP syndrome

Data collection included a comprehensive review of pathological histories, identification of complications based on clinical presentation, daily monitoring of biological parameters, documentation of transfusion events, recording of corticosteroid administration according to gestational age, and detailed reporting of extraction and analgesia techniques.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HELLP Syndrome Preeclampsia

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome Exclusion Criteria: * Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia. * Patients who benefited from plasma exchange therapy

Locations (1)

CHU Mohammed VI of Marrakech

Marrakesh, Marrakech - Safi, Morocco

RECRUITING

Outcomes

Primary Outcomes

Platelets count

Platelets count will be monitored daily before and after delivery

Time frame: Up to 10 days

Secondary Outcomes

Concentration of Lactate dehydrogenase

Monitored daily before and after delivery

Time frame: Up to 10 days

Concentration of Liver enzymes

daily monitoring of alkaline phosphatase, alanine transaminase before and after delivery

Time frame: Up to 10 days

Central Contacts

Nizar Amllah, M.D

CONTACT

+212 613069684 nizaramllah@gmail.com

Meryem Essafti, Assistant Professor

CONTACT

+212 662393700 essafti.m@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.